Robert Doody Jr.

Robert Doody joined Aclaris Therapeutics in September 2022 as Vice President, Investor Relations. Bob brings 20 years of communications and investor relations experience in the healthcare and pharmaceutical industry.

Prior to joining Aclaris, Bob served as Vice President of Investor Relations at Provention Bio. Previously, Bob served in leading IR and communications roles at Idera Pharmaceuticals and ViroPharma Incorporated, respectively. Bob began his communications career with Dorland Sweeney Jones, a health care public relations firm in Philadelphia.

Bob earned his Bachelor of Arts degree in communications from Rowan University after having served honorably in the United States Navy.